Jean-Marc Le Doussal

Person

Lausanne, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Humanized antibody against O-acetylated GD2 ganglioside (OAcGD2)
- Patent number 11,440,968
- Issue date Sep 13, 2022
- OGD2 PHARMA
- Mickaël Terme
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human IgG1 derived antibody with pro-apoptotic activity
- Patent number 10,669,328
- Issue date Jun 2, 2020
- OGD2 PHARMA
- Mylene Dorvillius
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody against GD2-O-acetylated ganglioside with pro-apoptotic ac...
- Patent number 10,611,848
- Issue date Apr 7, 2020
- OGD2 PHARMA
- Jean-Marc Le Doussal
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cosmetic composition comprising a muconopeptide
- Patent number 10,149,812
- Issue date Dec 11, 2018
- ACTIVEN
- Reto Stocklin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cosmetic composition comprising a muconopeptide
- Patent number 9,566,227
- Issue date Feb 14, 2017
- ACTIVEN
- Reto Stocklin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HUMANIZED ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE (OACGD2)
- Publication number 20230148349
- Publication date May 11, 2023
- OGD2 PHARMA
- Mickaël TERME
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITION MODULATING BOTULINUM NEUROTOXIN EFFECT
- Publication number 20230018920
- Publication date Jan 19, 2023
- FASTOX PHARMA SA
- Jean-Marc LE DOUSSAL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE TO IMPROVE THE...
- Publication number 20190375853
- Publication date Dec 12, 2019
- OGD2 PHARMA
- Stéphane BIRKLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMANIZED ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE (OACGD2)
- Publication number 20190233537
- Publication date Aug 1, 2019
- OGD2 PHARMA
- Mickaël TERME
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COSMETIC COMPOSITION COMPRISING A MUCONOPEPTIDE
- Publication number 20170157016
- Publication date Jun 8, 2017
- ACTIVEN
- Reto Stocklin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN IGG1 DERIVED ANTIBODY WITH PRO-APOPTOTIC ACTIVITY
- Publication number 20160280765
- Publication date Sep 29, 2016
- OGD2 PHARMA
- Mylene DORVILLIUS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY AGAINST GD2-O-ACETYLATED GANGLIOSIDE WITH PRO-APOPTOTIC AC...
- Publication number 20160272722
- Publication date Sep 22, 2016
- OGD2 PHARMA
- Jean-Marc LE DOUSSAL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COSMETIC COMPOSITION COMPRISING A MUCONOPEPTIDE
- Publication number 20150132235
- Publication date May 14, 2015
- ACTIVEN
- Reto Stocklin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Jean-Marc Le Doussal

Person

Patents Grantslast 30 patents

Humanized antibody against O-acetylated GD2 ganglioside (OAcGD2)

Human IgG1 derived antibody with pro-apoptotic activity

Antibody against GD2-O-acetylated ganglioside with pro-apoptotic ac...

Cosmetic composition comprising a muconopeptide

Cosmetic composition comprising a muconopeptide

Patents Applicationslast 30 patents

HUMANIZED ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE (OACGD2)

COMPOSITION MODULATING BOTULINUM NEUROTOXIN EFFECT

USE OF ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE TO IMPROVE THE...

HUMANIZED ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE (OACGD2)

COSMETIC COMPOSITION COMPRISING A MUCONOPEPTIDE

HUMAN IGG1 DERIVED ANTIBODY WITH PRO-APOPTOTIC ACTIVITY

ANTIBODY AGAINST GD2-O-ACETYLATED GANGLIOSIDE WITH PRO-APOPTOTIC AC...

COSMETIC COMPOSITION COMPRISING A MUCONOPEPTIDE